Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Amortizatization of Intangibles: 2018-2024

Historic Amortizatization of Intangibles for Arcutis Biotherapeutics (ARQT) over the last 7 years, with Dec 2024 value amounting to $6.9 million.

  • Arcutis Biotherapeutics' Amortizatization of Intangibles fell 66.78% to $562,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 2.18%. This contributed to the annual value of $6.9 million for FY2024, which is 1.26% down from last year.
  • According to the latest figures from FY2024, Arcutis Biotherapeutics' Amortizatization of Intangibles is $6.9 million, which was down 1.26% from $7.0 million recorded in FY2023.
  • Arcutis Biotherapeutics' 5-year Amortizatization of Intangibles high stood at $7.0 million for FY2023, and its period low was -$3.5 million during FY2021.
  • For the 3-year period, Arcutis Biotherapeutics' Amortizatization of Intangibles averaged around $5.4 million, with its median value being $6.9 million (2024).
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first tumbled by 1,137.24% in 2021, then surged by 210.21% in 2023.
  • Over the past 5 years, Arcutis Biotherapeutics' Amortizatization of Intangibles (Yearly) stood at $333,000 in 2020, then crashed by 1,137.24% to -$3.5 million in 2021, then spiked by 165.23% to $2.3 million in 2022, then soared by 210.21% to $7.0 million in 2023, then dropped by 1.26% to $6.9 million in 2024.